Literature DB >> 28969428

Is it possible to control HIV infection in a middle-income country through a multidisciplinary approach?

Jorge Casseb1, Luiz Augusto M Fonseca2, Alberto Duarte3.   

Abstract

Despite the difficulties to follow and retain patients for a long time in the public health service, special programs may bring about increased chances of survival and better quality of life, as well as higher rates of retention in care; this is also true for middle-income developing countries such as Brazil. Our relatively small outpatient service (~500 HIV-infected patients) may not mirror the reality encountered in other settings, including São Paulo city, but retention and high quality of care may improve rates of virologic success, even in poorer settings. Furthermore, prevention of depression or anxiety, with discussion in groups of patients with the presence of a therapist, regular HIV RNA viral and CD4 cells counts, genotyping tests pre-HAART, and vigilance for drug failure, may explain this successful experience. We should also take into consideration that our cohort consists mostly of asymptomatic at-entry patients referred by the Blood Bank of São Paulo, located at the same Hospital, implying that they had a better immunological status at start than the more usual HIV population. Besides that, the degree of adherence to treatment in our service, in general, is quite high and the patients have a higher mean educational level; over 90% of the patients a high school or college education . Such features make this cohort a very specific and differentiated sample. In order to extend our findings, we intend to conduct similar studies in other HIV treatment centers, enabling comparisons of populations with different profiles.

Entities:  

Mesh:

Year:  2017        PMID: 28969428     DOI: 10.1089/AID.2017.0106

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  1 in total

1.  Dichotomy in Fatal Outcomes in a Large Cohort of People Living with HTLV-1 in São Paulo, Brazil.

Authors:  Rosa Maria N Marcusso; Johan Van Weyenbergh; João Victor Luisi de Moura; Flávia Esper Dahy; Aline de Moura Brasil Matos; Michel E J Haziot; Jose E Vidal; Luiz Augusto M Fonseca; Jerusa Smid; Tatiane Assone; Jorge Casseb; Augusto César Penalva de Oliveira
Journal:  Pathogens       Date:  2019-12-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.